Payment overview · 2025
General Payments
$218.89
6 reported records · 4 companies
Healthcare provider profile · identity verified
John D Crase, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · NEW ALBANY, IN · NPI 1902820798
Verified facts
What the public records show
CMS Open Payments records show John D Crase, M.D. received $218.89 in general payments during 2025 across 6 reported records.
AstraZeneca Pharmaceuticals LP accounted for 54.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 32 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Symbicort by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $118.45 | 54.1% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $65.38 | 29.9% | 3 | 2025 |
| Philips North America LLC | Unresolved — no canonical attribution shown | $26.55 | 12.1% | 1 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $8.51 | 3.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $218.89 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $118.45 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $65.38 | 3 | 2025 |
Source payment records
|
|||||
| Holter Normalized: holter |
Device | Philips North America LLC | $26.55 | 1 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $8.51 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
32 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1021 | 242 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 559 | 103 |
| Amlodipine Besylate | Amlodipine Besylate | 518 | 136 |
| Lisinopril | Lisinopril | 518 | 133 |
| Levothyroxine Sodium | Levothyroxine Sodium | 469 | 101 |
| Losartan Potassium | Losartan Potassium | 412 | 99 |
| Gabapentin | Gabapentin | 381 | 81 |
| Metoprolol Succinate | Metoprolol Succinate | 379 | 87 |
| Omeprazole | Omeprazole | 356 | 83 |
| Pantoprazole Sodium | Pantoprazole Sodium | 333 | 66 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 331 | 88 |
| Furosemide | Furosemide | 325 | 74 |
| Lorazepam | Lorazepam | 242 | 46 |
| Eliquis | Apixaban | 235 | 39 |
| Potassium Chloride | Potassium Chloride | 225 | 42 |
| Metoprolol Tartrate | Metoprolol Tartrate | 222 | 55 |
| Glimepiride | Glimepiride | 218 | 57 |
| Alprazolam | Alprazolam | 217 | 36 |
| Metformin Hcl Er | Metformin Hcl | 216 | 54 |
| Tamsulosin Hcl | Tamsulosin Hcl | 210 | 48 |
| Hydrochlorothiazide | Hydrochlorothiazide | 207 | 49 |
| Allopurinol | Allopurinol | 202 | 42 |
| Zolpidem Tartrate | Zolpidem Tartrate | 200 | 34 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 187 | 53 |
| Duloxetine Hcl | Duloxetine Hcl | 187 | 37 |
| Citalopram Hbr | Citalopram Hydrobromide | 185 | 42 |
| Metformin Hcl | Metformin Hcl | 180 | 46 |
| Simvastatin | Simvastatin | 180 | 50 |
| Clopidogrel | Clopidogrel Bisulfate | 175 | 39 |
| Donepezil Hcl | Donepezil Hcl | 171 | 29 |
| Tramadol Hcl | Tramadol Hcl | 166 | 42 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 165 | 33 |
| Sertraline Hcl | Sertraline Hcl | 165 | 32 |
| Montelukast Sodium | Montelukast Sodium | 159 | 44 |
| Trazodone Hcl | Trazodone Hcl | 157 | 34 |
| Jardiance | Empagliflozin | 135 | 24 |
| Meloxicam | Meloxicam | 131 | 31 |
| Aripiprazole | Aripiprazole | 121 | 18 |
| Atenolol | Atenolol | 121 | 29 |
| Ozempic | Semaglutide | 112 | 17 |
| Hydralazine Hcl | Hydralazine Hcl | 108 | 33 |
| Carvedilol | Carvedilol | 107 | 26 |
| Memantine Hcl | Memantine Hcl | 107 | 14 |
| Spironolactone | Spironolactone | 103 | 28 |
| Escitalopram Oxalate | Escitalopram Oxalate | 102 | 26 |
| Baclofen | Baclofen | 100 | 24 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 97 | 18 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 95 | 74 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 94 | 21 |
| Bumetanide | Bumetanide | 93 | 23 |
| Bupropion Xl | Bupropion Hcl | 90 | 19 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 87 | 19 |
| Levetiracetam | Levetiracetam | 87 | 17 |
| Famotidine | Famotidine | 86 | 20 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 83 | 12 |
| Mirtazapine | Mirtazapine | 80 | 22 |
| Midodrine Hcl | Midodrine Hcl | 75 | 15 |
| Buspirone Hcl | Buspirone Hcl | 72 | 15 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 71 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 70 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 69 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 66 | 18 |
| Amitriptyline Hcl | Amitriptyline Hcl | 64 | 15 |
| Nystatin | Nystatin | 63 | 15 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 61 | 16 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 60 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 59 | 15 |
| Pregabalin | Pregabalin | 56 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 55 | 34 |
| Alendronate Sodium | Alendronate Sodium | 51 | 13 |
| Carisoprodol | Carisoprodol | 51 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 51 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 51 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 50 | 16 |
| Fenofibrate | Fenofibrate | 49 | 14 |
| Ondansetron Odt | Ondansetron | 48 | 23 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 47 | 13 |
| Fluticasone Propionate | Fluticasone Propionate | 47 | 20 |
| Tizanidine Hcl | Tizanidine Hcl | 46 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 45 | 13 |
| Colestipol Hcl | Colestipol Hcl | 44 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 44 | 12 |
| Prednisone | Prednisone | 44 | 21 |
| Pravastatin Sodium | Pravastatin Sodium | 43 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 42 | suppressed |
| Clonazepam | Clonazepam | 41 | 12 |
| Oxycodone Hcl | Oxycodone Hcl | 41 | 14 |
| Hydrocortisone | Hydrocortisone | 40 | suppressed |
| Diazepam | Diazepam | 39 | 12 |
| Diclofenac Sodium | Diclofenac Sodium | 38 | suppressed |
| Cephalexin | Cephalexin | 37 | 23 |
| Finasteride | Finasteride | 37 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 37 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 36 | suppressed |
| Mounjaro | Tirzepatide | 36 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 36 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 36 | 24 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 35 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 35 | suppressed |
| Valsartan | Valsartan | 34 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 33 | suppressed |
| Fluconazole | Fluconazole | 33 | 18 |
| Farxiga | Dapagliflozin Propanediol | 32 | suppressed |
| Humalog | Insulin Lispro | 32 | suppressed |
| Ibuprofen | Ibuprofen | 32 | suppressed |
| Methylprednisolone | Methylprednisolone | 32 | 29 |
| Acyclovir | Acyclovir | 29 | suppressed |
| Digoxin | Digoxin | 29 | suppressed |
| Estradiol | Estradiol | 29 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 28 | suppressed |
| Azithromycin | Azithromycin | 28 | 24 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 28 | suppressed |
| Fentanyl | Fentanyl | 28 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 28 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 28 | suppressed |
| Glipizide | Glipizide | 27 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 27 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 27 | suppressed |
| Cefdinir | Cefdinir | 26 | 20 |
| Synthroid | Levothyroxine Sodium | 26 | suppressed |
| Pentoxifylline | Pentoxifylline | 25 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 24 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 24 | suppressed |
| Myrbetriq | Mirabegron | 24 | suppressed |
| Lamotrigine | Lamotrigine | 23 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 23 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 23 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 22 | suppressed |
| Trulicity | Dulaglutide | 21 | suppressed |
| Gemtesa | Vibegron | 20 | suppressed |
| Nyamyc | Nystatin | 20 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 20 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 20 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 19 | suppressed |
| Klor-Con M20 | Potassium Chloride | 19 | suppressed |
| Nabumetone | Nabumetone | 19 | suppressed |
| Amoxicillin | Amoxicillin | 18 | 13 |
| Ceftriaxone | Ceftriaxone Sodium | 18 | 11 |
| Lacosamide | Lacosamide | 17 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 17 | 11 |
| Methotrexate | Methotrexate Sodium | 17 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Celecoxib | Celecoxib | 16 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 16 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 16 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 16 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 16 | suppressed |
| Risperidone | Risperidone | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 15 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 15 | 12 |
| Morphine Sulfate Er | Morphine Sulfate | 15 | suppressed |
| Primidone | Primidone | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Ursodiol | Ursodiol | 15 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 15 | suppressed |
| Xarelto | Rivaroxaban | 15 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 14 | 14 |
| Calcium Acetate | Calcium Acetate | 14 | suppressed |
| Ezetimibe | Ezetimibe | 14 | suppressed |
| Febuxostat | Febuxostat | 14 | suppressed |
| Loperamide | Loperamide Hcl | 14 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 14 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 14 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | 11 |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Ranolazine Er | Ranolazine | 13 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Amantadine | Amantadine Hcl | 12 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 12 | suppressed |
| Premarin | Estrogens, Conjugated | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Torsemide | Torsemide | 12 | suppressed |
| Calcitriol | Calcitriol | 11 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 11 | suppressed |
| Dutasteride | Dutasteride | 11 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 11 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Methylphenidate Er | Methylphenidate Hcl | 11 | suppressed |
| Nadolol | Nadolol | 11 | suppressed |
| Naproxen | Naproxen | 11 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $218.89 · 6 records | AstraZeneca Pharmaceuticals LP | AIRSUPRA, Cologuard Collection Kit, Holter, VOQUEZNA | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error